They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Novo Nordisk has rebounded strongly in 2025, backed by solid financials despite earlier setbacks and competitive risks. See ...

Novo Nordisk’s annual report contains an interesting footnote on its key drug, Ozempic, which last year accounted for $19 ...

NYU's Scott Galloway has a few metaphors to help workers make sense of the sweeping changes AI is bringing to the workplace.

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...

A study from Mass General Brigham and Harvard Medical School raises questions about a new class of weight loss drugs — and ...

President Trump says it’s a ‘done deal’ with China on trade, but inside the supply chain, the damage has been done and will ...

Could GLP-1 weight loss drugs like Ozempic and changing economic winds really take a bite out of the almighty Big Mac?

Researchers say people with schizophrenia are facing an "epidemic" of obesity-related diseases, with weight gain a common ...

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.